Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How again will this be any more compelling than the Q that was JUST published showing several hundred percent increase in revs y/y and roughly 80% REDUCTION in net loss—and yet we’re STILL falling?! WT absolute F!!!!!
And that’s why someone SOLD 3M shares today at .0039???
Many months ago I speculated about whether this is why the PPS was quietly being allowed to remain down despite so many indications of VERY positive business developments. Other related questions: (1) does splitting CaverStem off make it any more/less likely that they would entertain buyout? (2) what exactly will be the impact of the split-off on current shareholder equity? (3) does CaverStem international INCLUDE current US interests (would seem to make more sense—why would they bifurcate yet again by having TWO CaverStem entities?)? In the end, I cannot see them selling everything (why would they with so much in development that we have no way to estimate the value of?). If ANYTHING is sold, it would probably be CaverStem (which has been split off already) and then using that money to promote and commercialize all the other product lines, beginning with Femcelz and Amniostem. LASTLY, given the indications that CaverStem results in growth of NEW vessels and the implications of this for increasing size, they’d better not settle for ANYTHING other than a MASSIVE payday for CaverStem alone!
Is that your assertion? I THINK that’s what you’re saying. But then what did you mean at the end when you wrote “yahoo ?” ?
“Soon”: we’re starting to sound like believers anticipating the second coming—2,000 years later...
Not particularly. But I can say that I was consistently sounding alarms that others have finally come to accept...
+1
I’m WAY over their heads (I saw this a year ago).
Sources? If it’s not documented it didn’t happen. Let’s avoid the foggy, the nebulous, and the imprecise—in favor of the clear, the cogent, and the compelling. No more abstractions: we should not be approaching this as s proof-of-concept...
Good overall—but not good ENOUGH: if/when something mentions CaverStem and/or Femcelz specifically (instead of the boilerplate “autologous bone marrow stem cells”), THEN I will get excited. Until then, we continue to lurk in obscurity.
Can someone find the short interest % of BANT (formerly DRUS) over the last year or so? Someone on the board of another stock made an interesting comment about an event they witnessed: “certain” well-financed interests who are able to naked short shorted the stock all the way down in an effort to kill the company. Would be interesting to see whether dramatic increase in short % coincided with our drop in PPS from around .005.
Can someone find the shirt interest % of BLSP over the last year or so? Someone on the board of another stock made an interesting comment about an event they witnessed: “certain” well-financed interests who are able to naked short shorted the stock all the way down in an effort to kill the company. Would be interesting to see whether dramatic increase in short % coincided with our drop in PPS from around .03.
But as of 6/1 we were NOWHERE near as low as .0050
In other words, those $13M are really share options?
Of course stock options are an expense. What I REALLY need to know is (1) who, if anyone, is getting those options, (2) where in their filings are stock options addressed (whether as a line-item, or in narrative—or preferably both), and (3) are DOCTORS receiving/eligible to receive stock options when they go under contract? We need ANSWERS!
No trades at all today?
Where do you honestly see the PPS in 5 years—best guess?
All those Jewish investors (documented) and national governments that invested so deeply in BLSP must have no idea what they have invested in/gone under legally binding contracts with then? Absurd.
Thanks!
Indeed: a roughly 80% REDUCTION in net loss in one quarter—and they haven’t even gotten started with serious expansion yet! Makes achieving a positive EPS during 2019 seem very likely.
EPS updated on TDA—now listed
as -.0108 (up from -.05)
At the moment I REGRET the decision to remain here—but I still believe in the POTENTIAL. It’s time for some kinesthesis though...
By this time in 2018 we were rising daily—and WAY HIGHER than .005. So sad to see intelligent and committed people rationalizing and attempting to explain away the obvious things that have been staring us in the face for over a year—in spite of all the “positive developments.” Not investing another cent until this shows a PULSE
I once believed this fervently. However 1.5 years is a LONG time for something with this much putative value: if it’s as plain to see as the nose on our faces, then why does NO ONE see it? Why did the market barely burp and laugh as it spit us out at .07? There should be a feeding frenzy here in pursuit of those “billions”...
No and I can’t see on my phone. Can you (briefly) summarize?
Meaning???
35 mins into trading—zero trades??
Theory: CELZ wishes/intends to keep PPS at or below conversion price listed for institutional investors in late 2018 (I think it’s around 2¢/share). Plausible? Will continue to beat the drum until we get answers!
But you will presumably agree that, IF they are to cash in “bigly” with CaverStem and Femcelz, then something keyed to those patents must be directly connected to revenues and profits? There is considerable money SOMEWHERE if (a) they believe they will be self-sustaining THIS YEAR and (b) the reworked notes that remain are now held by investors who think they will cash in. Just trying to piece some tea leaves together...
Yes, I recall that. Thank you for refreshing it here.
So again, what would be the point (or IS there one) to their several patents if they cannot be directly monetized?
But it is my understanding that they do not have a patent on the kit (which they essentially resell). However, they do apparently have patents on the procedures—which makes me think that these are somehow monetized: otherwise, what would be the point of securing the patents?
WHEN (if EVER) will we have a CLEAR exposition of ALL revenue streams?!?! SURELY it’s not merely a matter of “selling kits” (where the the profit is BELIEVED to be around $1,500 per kit). Where is the revenue management plan??? If the “institutional investors” deserve to see it (how else would CELZ approach making the case for their funding support), then why doesn’t the entire group of investors???
Fair enough. “Some” will always say negative stuff. And yes, I would prefer that whatever they say can be substantiated—which brings me to my point: do they have NOTHING of substance?
Can someone tell them that this is the 21st century and that carrier pigeons and other glacial forms of communication are no longer used functionally? Thanks
Yet more hemorrhagic activity. Unreal
And even more fundamentally from the perspective business operations and communications: how is it possible that, after about ONE YEAR of commercialization, WE STILL do not have a CLEAR EXPLANATION of precisely how what they are “commercializing” is being monetized?! What PRECISELY are the revenue streams? What do then pipelines that feed these look like (in terms of general structure, NOT specific numbers)? It is asinine and absurd that I am the only one asking these questions (and pissed and perplexed by the absence of answers!). In the immortal words of Vince Lombardi: “What the h3ll is going ON out there?!”
You mean the companies with multi-billion dollar market caps and PPSs in the $25-100 dollar range? We might wanna get out PPS to a dime and keep it their for a few quarters before we go to extremes! The stupid (and sad) thing is that some actually believe that CELZ is so quiet because they’re gonna “sneak up on the enemy.” What a farce: (a) assuming that we have something worth having (our PPS CONTINUES to suggest otherwise now for more than one year), the enemy ALREADY KNOWS about us, which (b) makes the silence even more ludicrous and infuriating.
The market doesn’t even laugh or burp at this crap anymore. Pathetic
These professional profiles are very well known to anyone who has been here—and I would advise caution to anyone new: don’t become too entranced by their credentials—on paper this looks like a no-brainer, but there’s something BADLY missing in the areas of communication and timely follow through. They want mindlessly loyal, obsequious investors (to the extent that they care AT ALL), so check your critical thinking, argumentation, and writing skills at the door: they deal best with a disarmed and compliant audience. So yes, their professional profiles look great, but their implementation has been nothing short of glacial: they continue to duck and dodge in the shadows, while our shareholder value (PPS) gets CRUSHED in the light of day...
+1
I’ve been BEGGING them to prove us wrong for over a year now. At some point they need to start acting like they’re big league players (if, in fact, they are): I just don’t think they have what it takes. They continue to duck and dodge in the shadows, while our shareholder value gets CRUSHED in the light of day...